Evidence map›Paper›PMID 28055140›Full record

ArticleHuman mutation2017

EIF2S3 Mutations Associated with Severe X-Linked Intellectual Disability Syndrome MEHMO.

Martina Skopkova, Friederike Hennig, Byung-Sik Shin, Clesson E Turner, Daniela Stanikova, Katarina Brennerova, Juraj Stanik, Ute Fischer, Lyndal Henden, Ulrich Müller and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in Human mutation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Distinct cell type-specific mechanisms underlie cognitive dysfunction during persistent integrated stress response activation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. The ISR downstream target ATF4 represses long-term memory in a cell type-specific manner.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Article
  13. Article
  14. Human Tissues Exhibit Diverse Composition of Translation Machinery.International journal of molecular sciences · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 13 institutions in 6 countries.

Martina SkopkovaDIABGENE & Laboratory of Diabetes and Metabolic Disorders, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
Friederike HennigResearch Group Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Byung-Sik ShinEunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
Clesson E TurnerDepartment of Genetics, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
Daniela StanikovaDIABGENE & Laboratory of Diabetes and Metabolic Disorders, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
Katarina BrennerovaFirst Department of Pediatrics, Medical Faculty of Comenius University, Bratislava, Slovakia.
Juraj StanikDIABGENE & Laboratory of Diabetes and Metabolic Disorders, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
Ute FischerResearch Group Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Lyndal HendenPopulation Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
Ulrich MüllerInstitut für Humangenetik, Justus-Liebig-Universität Giessen, Giessen, Germany.
Daniela SteinbergerInstitut für Humangenetik, Justus-Liebig-Universität Giessen, Giessen, Germany.
Esther Leshinsky-SilverInstitute of Medical Genetics, Wolfson Medical Center, Holon, Israel.
Armand BottaniService of Genetic Medicine, Geneva University Hospitals, Geneva, Switzerland.
Timea KurdiovaDIABGENE & Laboratory of Diabetes and Metabolic Disorders, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
Jozef UkropecDIABGENE & Laboratory of Diabetes and Metabolic Disorders, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
Olga NyitrayovaCytopathos, Bratislava, Slovakia.
Miriam KolnikovaDepartment of Pediatric Neurology, Medical Faculty of Comenius University, Bratislava, Slovakia.
Iwar KlimesDIABGENE & Laboratory of Diabetes and Metabolic Disorders, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
Guntram BorckInstitute of Human Genetics, University of Ulm, Ulm, Germany.
Melanie BahloPopulation Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
Stefan A HaasDepartment of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Joo-Ran KimEunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
Leda E Lotspeich-ColeEunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
Daniela GasperikovaDIABGENE & Laboratory of Diabetes and Metabolic Disorders, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
Thomas E DeverEunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
Vera M KalscheuerResearch Group Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Slovak Academy of Sciences · SKMax Planck Institute for Molecular Genetics · DEComenius University Bratislava · SKNational Institutes of Health · USUniversity of Giessen · DEEunice Kennedy Shriver National Institute of Child Health and Human Development · USInstitute of Experimental Endocrinology of the Slovak Academy of Sciences · SKUniversität Ulm · DEUniversity Hospital of Geneva · CHUniversity of Melbourne · AUWalter and Eliza Hall Institute of Medical Research · AUWalter Reed National Military Medical Center · USWolfson Medical Center · IL

Funding

Mechanism and Regulation of Eukaryotic Protein SynthesisZIAHD001010 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI DEVER, THOMAS E · 2009 to 2025
$29.4M
REGULATION OF EUKARYOTIC PROTEIN SYNTHESISZ01HD001010 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI DEVER, THOMAS E · 1995 to 2008
$2.6M
Intramural NIH HHS Z01 HD001010
6 · The paper itself

Abstract

Impairment of translation initiation and its regulation within the integrated stress response (ISR) and related unfolded-protein response has been identified as a cause of several multisystemic syndromes. Here, we link MEHMO syndrome, whose genetic etiology was unknown, to this group of disorders. MEHMO is a rare X-linked syndrome characterized by profound intellectual disability, epilepsy, hypogonadism and hypogenitalism, microcephaly, and obesity. We have identified a C-terminal frameshift mutation (Ile465Serfs) in the EIF2S3 gene in three families with MEHMO syndrome and a novel maternally inherited missense EIF2S3 variant (c.324T>A; p.Ser108Arg) in another male patient with less severe clinical symptoms. The EIF2S3 gene encodes the γ subunit of eukaryotic translation initiation factor 2 (eIF2), crucial for initiation of protein synthesis and regulation of the ISR. Studies in patient fibroblasts confirm increased ISR activation due to the Ile465Serfs mutation and functional assays in yeast demonstrate that the Ile465Serfs mutation impairs eIF2γ function to a greater extent than tested missense mutations, consistent with the more severe clinical phenotype of the Ile465Serfs male mutation carriers. Thus, we propose that more severe EIF2S3 mutations cause the full MEHMO phenotype, while less deleterious mutations cause a milder form of the syndrome with only a subset of the symptoms.

Indexed as

EpilepsyHypogonadismMicrocephalyMutationAmino Acid SequenceEukaryotic Initiation Factor-2Family HealthFemaleGenitaliaHumansIntellectual DisabilityMaleObesityPedigreeSequence Analysis, DNASequence Homology, Amino AcidEukaryotic Initiation Factor-2EIF2S3integrated stress responseMEHMO syndrometranslation initiationunfolded-protein responseXLID

Identifiers

PMID28055140
PMCPMC6267786
OpenAlexW2569196904

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.